SIMSBURY, Conn., Aug. 30, 2019 /PRNewswire/ -- Tolk Chiropractic & Wellness launches

DUBLIN, Aug. 30, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the Company and its U.S. subsidiaries have reached a settlement with plaintiffs scheduled for trial in October 2019 in the federal opioid multidistrict litigation. As part of the agreement, Allergan will pay $1.9 million to

CHARLOTTE, N.C., Aug. 30, 2019 /PRNewswire/ -- Nugenix®, an elite men's health supplement brand, was recently named GNC's "Top Product of the Year" for the second consecutive year (NYSE: GNC). Th

BALTIMORE, Aug. 30, 2019 /PRNewswire/ -- Prostate cancer is the second most common cancer for men, both in the United States and worldwide. In 2019, nearly 175,000 US men will be told they have prostate cancer – that is one new case every 3 minutes. Globally, the number increases to one new case every 41 seconds.E

BRENTWOOD, Tenn., Aug. 30, 2019 /PRNewswire/ -- AAC Holdings, Inc. (NYSE: AAC) ("the Company" or "AAC") announced financial results for the second quarter and six months ended June 30, 2019, as well as updated 2019 guidance.Second Quarter 2019 Operational and Financial Highlights:(All comparisons are to first qua

SUZHOU, China, Aug. 30, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the clinical trial results of IBI303, an anti-tumor necrosis factor-alpha (anti-TNF-alpha) mono

STOCKHOLM, Aug. 30, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that new updated melflufen data from the Phase 2 pivotal OP-106 HORIZON study will be presented at at the 17th International Myeloma Workshop (IMW) meeting on September 15, Boston, Massachusetts, USA. The

STOCKHOLM, Aug. 30, 2019 /PRNewswire/ -- Essity and UNICEF in Mexico have entered into a new agreement to jointly promote awareness of the importance of good hand hygiene and to break the taboos around menstruation. Over the next three years, the collaboration will provide education to 4,000 pupils and 500 teachers in

LUND, Sweden, Aug. 30, 2019 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that new imlifidase data will be highlighted in a presentation at the 19th Congress of the European Society for Organ Transplantation (ESOT), taking place September 15 to 18, 2019 in

STOCKHOLM, Aug. 30, 2019 /PRNewswire/ -- WntResearch and The Sage Group have initiated a collaboration to accelerate the process of identifying and engaging potential partners prior to readout of the on-going Phase 2 study with Foxy-5.Cancer is by far the largest research area in the pharmaceutical industry and the number of companies focusing on developing